Medtech Spectrum: Discovering the Intersection of Medical Technology and Healthcare Advancements

Article Name Artificial Intelligence

Japan produces world's first report on brain activation by Plasmacluster Technology

Validation of the mechanism of its enhancing effect on human work performance by measuring brain function ...Read more

27th July, 2023

Medlinker's MedGPT Performs 96% As Well As Top Human Doctors

In a Livestreamed Real-World Assessment, MedGPT's AI Doctors Rival Diagnostic Accuracy of China's Leading Doctors...Read more

24th July, 2023

Lark Health and Desert Oasis Healthcare Announce Expanded Partnership

Lark Health, the leading AI-powered digital care coaching company for the prevention and management of chronic conditions, and Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, today announced their...Read more

21st July, 2023

Verantos' AI Advancement in Neurology Bolstered by Groundbreaking Migraine Real-World Evidence

Technology enables inference of subjective outcomes from routinely collected data...Read more

20th July, 2023

Astellas and Eko Health Partner to Integrate Eko CORE 500™ Stethoscope into Z1608 for Heart Failure Patients

Transforming Heart Failure Management: Astellas, Eko Health & Welldoc Collaborate...Read more

19th July, 2023

Optina's REPHRASE Study Validates Innovative Alzheimer's Test

Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr...Read more

18th July, 2023

DiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay Development

DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into an agreement with JADBio to utilize its Automated Mach...Read more

10th July, 2023

CMS Introduces HCPCS Code for Ultromics EchoGo® Heart Failure, Enhancing HFpEF Detection Access

Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment of a new outpatient code by the Centers for Medicare and Medicaid ...Read more

06th July, 2023

Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker

Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnorma...Read more

06th July, 2023